Closing Bell: HIMS Surges, Uber & DoorDash Sinks, Paramount Drops

Nova Nordisk, which has been struggling as it tries to find its way in what has become an increasingly competitive JLP one landscape, it too, up about three point one percent, so we've got that playing out. Also, kind of staying in the drugs and biotech space, a lot of movement in the area for some companies, and some of it has to do with the head of the FDA's Division of Vaccines and Gene Therapies set to leave the agency

next month. We talked with Bloomberg's Medicin Mueller. This is a pretty big deal for some companies in the biotech space or the space overall, so capricor therapeutics. It's a one point six billion dollar market cap, clinical stage biotech. It's working on biological therapies. That one was up almost ten percent in today's session, has been higher all day.

And then another one regen x Bio, also a clinical stage biotech companies small market cap about five hundred and forty two million market cap there developing gene therapy products. But that one too, the expectation maybe a better and some more supportive landscape from the FDA for these kinds of companies and the work that they're doing. That one was up about twenty percent. And then just quickly, let's go on over to Live Nation News for that one.

The company and its ticket master subsidiary have reached a settlement with federal anti trust authorities. According to the Justice Department. The agreement announced, but it would reportedly open up parts of Live Nation's ticketing armed to third party sellers make it easier for other promoters to put on shows that amphitheaters, that live nation controls, and you can see that one. Whenever you get rid of some litigation overhead overhang, you can see it pop to the pside up about six

point two percent. That's what it's going to add.

costs rise. We heard that some airlines were considering halting jet deliveries, which we know when we think about contracts with Boeing, a lot of these things are done far out, so really just casting some uncertainty here in the market. Some airlines were said to also pause leasing and order discussions, so you certainly saw that weighing on sentiment here for investors of Boeing. But keeping an eye on all the implications that we've been seeing in terms of the ongoing

conflict in the Middle East. Of course, we've got the headlines coming out earlier about what the outlook could be and how long this actual conflict could last. But there were some stocks that of course have exposure to the oil space, and taking a look at shares of Uber, they ended lower by about one point seven percent, door Dash and Focus that went down about one zero point

four percent at the closing bell. Now, this of course is due to the idea that these companies actually have exposure to the costs for fuel oil and the idea that these all this pressure could really trickle out into

the consumer and make things more expensive. We know ubers, at least here in New York City are already expensive, with a lot of these surcharges, but thinking about that just actually coming into door Dash and Uber and whether or not that could actually weigh on consumers and the companies more broadly, and lastly, wrapping things up, I've got my eyes on Paramounts Guidance. We know that this is

a story that's really been evolving day after day. If we think about Paramounts Guidance and Warner Brothers Discovery, that battle that we saw between Paramounts Guidance and Netflix that we know paramount did win here. So we do see shares down about six point seven percent on the day. This is after ten cents at an intense a best several hundred million dollars.